GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Other Long-Term Liabilities

Star Lake Bioscience Co (SHSE:600866) Other Long-Term Liabilities : ¥227 Mil (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Other Long-Term Liabilities?

Star Lake Bioscience Co's other long-term liabilities for the quarter that ended in Mar. 2024 was ¥227 Mil.

Star Lake Bioscience Co's quarterly other long-term liabilities declined from Sep. 2023 (¥358 Mil) to Dec. 2023 (¥334 Mil) and declined from Dec. 2023 (¥334 Mil) to Mar. 2024 (¥227 Mil).

Star Lake Bioscience Co's annual other long-term liabilities increased from Dec. 2021 (¥465 Mil) to Dec. 2022 (¥564 Mil) but then declined from Dec. 2022 (¥564 Mil) to Dec. 2023 (¥334 Mil).

Star Lake Bioscience Co Other Long-Term Liabilities Historical Data

The historical data trend for Star Lake Bioscience Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Other Long-Term Liabilities Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Star Lake Bioscience Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Star Lake Bioscience Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Other Long-Term Liabilities
Comparable Companies
SZSE:300841 SHSE:688526 SZSE:002275 SZSE:301047 SZSE:000990 SHSE:600645 SHSE:600200 SHSE:688197 SHSE:600201 SHSE:605116 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Website
http://www.starlake.com.cn
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines